Whether you’re celebrating a funding round, research collaboration, FDA-approval, or commemorating a deal in the biotech space, you’ll find inspiration in the custom designs below.

Custom Commemorative for Drug Licensing Agreement

Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.

(20ALJ071)
1 Image

Sensor-Themed Deal Tombstone

Custom deal tombstone commemorating the acquisition of Van London, a Texas-based designer and manufacturer of high-quality sensors for the industrial, lab, and biotech markets.

(9AKL686)
1 Image

Double Helix-Themed Deal Toy

Custom deal toy marking a follow-on stock offering by Translate Bio. The biotech firm specializes in the treatment of diseases caused by protein or gene dysfunction.

(9ALJ491)
2 Images
Custom Lucite tombstone recognizing a follow-on offering by Translate Bio. The Boston-area therapeutics firm focuses on diseases caused by protein or gene dysfunction.

Bioscience Offering Deal Toy

Crystal deal toy marking two offerings by Yield10 Bioscience, which specializes in the development of high-yield seeds for the agricultural and food industries.

(9AMF367)
2 Images
Custom financial tombstone marking a private placement and direct offering by Yield10 Bioscience. The Woburn, Massachusetts-based company develops seed technology to increase crop yield.

Regulatory Services Lucite Tombstone

Lucite tombstone marking the acquisition of Catalyst Regulatory Services, which provides regulatory support for biopharmaceutical firms.

(20AMF027)
1 Image

Medical Technology Lucite Tombstone

Lucite tombstone commemorating a follow-on offering by medTech firm Viveve Medical, which specializes in women’s health.

(20AMF021)
2 Images
Lucite financial tombstone marking a follow-on offering by Englewood, Colorado-based Viveve Medical.

Follow-On Offering Financial Tombstone

Custom financial tombstone recognizing a follow-on offering by Turning Point Therapeutics. Turning Point is a clinical-stage biopharmaceutical company focused on oncology therapies.

(9ALJ524)
1 Image

Pharmaceutical Public Offering Tombstone

Lucite tombstone commemorating a public offering of stock by Achieve Life Sciences. Achieve is engaged in the development and cytisinicline, a plant-based alkaloid used for smoking cessation and nicotine addiction.

(20AMF022)
1 Image

Mountain-Themed “Summit” Award

(20AKL59)
2 Images

Biotech Deal Toys

Beginning on this page, you’ll find galleries with over 90 images of financial tombstones and deal toys from the biotech and life sciences space. You’ll find a number of custom designs playing off visual elements commonly associated with this space, including DNA strands, pills, lab beakers, periodic tables, as well as ones incorporating actual drug vials.

As you might also expect, you’ll see a number of deal toys involving internationally recognized firms and players. These include Takeda Pharmaceutical, Horizon Therapeutics, Gilead Sciences, Roche, Neurocrine, and Bayer. You’ll see as well tombstones commemorating transactions common to this sector involving these and other firms: joint ventures, licensing deals, and development and commercialization agreements.

But you’ll also notice a number of deals commemorated here that may involve far less familiar firms. These include the acquisition of a Dutch company focused on live-cell imaging analytics, and one of an Illinois-based gene therapy firm devoted to the treatment of a rare genetic disorder; the initial public offering of an Australian developer of radiopharmaceutical cancer therapies, and the IPO of a Norwegian biotech making use of marine compounds such as herring roe extract; early-stage funding for a Philadelphia gene engineering startup, and the IPO of an Israeli firm focused on medical applications for lipid-based compounds.

You’ll also notice in these galleries designs not related to any financial transaction. These celebrate a range of awards and employee recognition pieces honoring successful clinical trials, Food and Drug Administration (FDA) and New Drug Application (NDA) submissions, research collaborations and partnerships, and product development milestones.